Insider buying last 90 days
No open-market insider purchases were filed for NVST in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every NVST insider filing, plotted on the chart in Gekko.Open NVST in Gekko
NYSE: NVST
Envista (NVST) Stock Analysis & Forecast
Oct 12 close
$22.72−0.28 (−1.2%)
Gekko Brief
AI summaryOct 12 closeEnvista draws several analyst notes this week. Piper Sandler cut its price target to $26 from $28 while keeping a Neutral rating, citing inventory drawdown headwinds in the orthodontic business, while Bank of America reiterated a Buy rating with a $34.00 price target. Separately, the stock carries a consensus "Hold" rating from covering brokerages, and Envista has scheduled its third-quarter 2026 earnings call for 4 November 2026.
Envista closed at $22.72, down 1.2%, sitting below both its 50-day average of $25.87 and its 200-day average of $25.69. The stock's one-month return stands at -11.1% and its three-month return at -13%, though it remains up 12.5% over the past year. The GekkoIndex reads 66.2, placing it in the Accumulation zone, and the gap to Gekko Fair Value of $34.09 stands at -33.4%.
Envista's next earnings report lands on 4 November 2026 after close, 23 days away, falling inside a typical 20-trading-day holding window; the prior report on 5 August 2026 beat estimates with EPS of $0.41 versus $0.33 expected, though shares reacted -2.1%, with average absolute moves of 7.8% around results historically. Seasonality from this point in the calendar has averaged +4.4% over the next 20 trading days across 5 years, rising in 4 of them. No insider, Congress or unusual options activity appears in the current window.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Envista price vs fair value
Close $22.72200-day averageGekko Fair Value $34.09
Envista quick facts
- Market cap
- $3.70B
- P/E ratio
- 39.2
- Forward P/E
- 16.8
- EPS, TTM
- $0.58
- Revenue, TTM
- $2.86B
- Profit margin
- 3.3%
- Dividend yield
- —
- Beta
- 0.89
- Volume
- 2.39M avg 3.00M
- 1-year return
- +12.5%
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±6.8%
- 50-day average
- $25.87
- 200-day average
- $25.69
- Next earnings
- Nov 4 after close
- Shares outstanding
- 160.6M
Envista swing-trade checklist
Envista scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendmixed
Averages disagree
Close $22.72 sits between the 50-day ($25.87) and 200-day ($25.69) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
66.2, Accumulation
Reading 66.2 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
33.4% below
Price is 33.4% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 23 days
Reports on Nov 4, 2026, 23 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+4.4% on average
From this point in the calendar, the next 20 trading days averaged +4.4% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Envista stock chart and price history
Envista closed at $22.72 on Oct 12, 2026, +12.5% over the past year, inside a 52-week range of $18.77 to $30.42.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −11.1%
- 3 months
- −13.0%
- 6 months
- −15.6%
- 1 year
- +12.5%
The full NVST chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open NVST in Gekko
Follow Envista through every session
Put NVST on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track NVST in GekkoFree for 7 days. No credit card required.
About Envista
Envista develops and sells dental products used to diagnose, treat and prevent problems affecting teeth, gums and the bone that supports them. Its work spans tools and materials used by dental professionals across both clinical treatment and preventive care, giving it a presence in many parts of everyday dental practice.
The company runs its operations through two divisions. One, Specialty Products & Technologies, focuses on dental implant systems, prosthetic devices and related digital treatment software, along with orthodontic items such as brackets, clear aligners and dental laboratory supplies. The other, Equipment & Consumables, designs and markets equipment and supplies for dental offices, including imaging systems and magnification tools, treatment chairs and fixtures, endodontic kits and consumables, restorative materials, burs, impression materials, adhesives, cements and infection control products. Its customers are dental practices and clinics that rely on these tools for daily patient care.
Envista is headquartered in Brea, California, and employs 12,800 full-time staff. Its shares are listed on the NYSE under the ticker NVST.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- envistaco.com
Envista GekkoIndex: the smart money zone
Envista’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.2, in the Accumulation zone, down 0.6 points over five sessions.
66.2Accumulation
Down 0.6 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 33 | −1.1% | −1.6% | ||
| Accumulation (current zone) | 248 | −0.1% | +0.7% | ||
| Neutral | 365 | +0.6% | +0.5% | ||
| Distribution | 35 | −2.0% | +0.5% | ||
| Selling | 1 | Too few readings yet | |||
Average NVST share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the NVST price, zone by zone.Track NVST in Gekko
Is Envista stock overvalued? Gekko Fair Value
Envista trades 33.4% below Gekko Fair Value of $34.09, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Envista shares are worth, recalculated every trading day.
$34.09
Gekko Fair Value, Oct 10, 2026
33.4% Undervalued
At the end of Aug 2026 the price was 24.7% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open NVST in Gekko
Envista insider and Congress trading
No open-market insider purchases were filed for Envista, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in NVST were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for NVST, plotted on the chart in Gekko.Open NVST in Gekko
Buybacks
Envista has been buying back its own shares.
- Bought back, quarter ended Jul 3, 2026
- $103.0M
- As a share of market cap
- 2.79%
- Trailing four quarters
- $212.0M
From company filings.
Hedge funds and billionaires quarter ended Mar 31
0of the funds Gekko tracks hold NVST.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Envista earnings: next date and track record
Envista reports on Nov 4, 2026, after the close (23 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 4, 2026
Expected after the close, 23 days away
- EPS estimate
- $0.36
- Revenue estimate
- $688.8M
8 of 8reports beat the EPS estimate
±7.8%average move across the report
6 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 5, 2026 AI summary
- What they said
- Envista delivered Q2 2026 core growth of 5%, with first-half core growth exceeding 7%. Spark aligners grew double digits, consumables/diagnostics up high single digits, implants up low single digits. Adjusted EBITDA rose 28%, EPS grew 58%, and free cash flow conversion hit 158%. Gross margin expanded 70bps and EBITDA margin expanded 230bps. The company repurchased 2.4 million shares in Q2.
- Guidance
- Envista raised full-year 2026 guidance: core growth now expected at 3.5%-4.5%, adjusted EBITDA growth of 11%-14%, and adjusted EPS of $1.50-$1.55, reflecting strong first-half momentum and continued execution.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $0.41 est $0.33 | $730.5M est $716.1M | −2.1% |
| May 6, 2026 | $0.36 est $0.31 | $705.5M est $680.0M | −7.3% |
| Feb 5, 2026 | $0.38 est $0.32 | $750.6M est $680.0M | +23.0% |
| Oct 29, 2025 | $0.32 est $0.27 | $669.9M est $680.3M | +0.4% |
| Jul 31, 2025 | $0.26 est $0.24 | $682.1M est $642.5M | +4.4% |
| May 1, 2025 | $0.24 est $0.20 | $616.9M est $635.7M | +5.7% |
| Feb 5, 2025 | $0.24 est $0.22 | $652.9M est $645.9M | +8.2% |
| Oct 30, 2024 | $0.12 est $0.09 | $601.0M est $647.7M | +11.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Envista stock forecast and analyst price targets
Analysts’ average 12-month price target for Envista is $29.69, +30.7% from the last close, from 15 firms rating the stock in the last 90 days.
$29.69consensus 12-month target, +30.7% from the last close
Now $22.72Avg $29.69
Low $23High $35
Each firm’s latest rating in the last 90 days: 15 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 9 | Piper Sandler | $26 | +14.4% |
| Oct 7 | Bank of America Securities | $34 | +49.6% |
| Oct 2 | William Blair | — | — |
| Sep 28 | BMO Capital | $26 | +14.4% |
| Sep 28 | Bank of America Securities | $34 | +49.6% |
+0.7%average 20-day move after past Accumulation readings
+4.4%average move over the next 20 trading days in the last 5 years
±2.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Envista seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Envista averaged +4.4% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.2% | 3 of 5 |
| Next 10 trading days | +1.8% | 3 of 5 |
| Next 15 trading days | +1.0% | 4 of 5 |
| Next 20 trading days | +4.4% | 4 of 5 |
| Next 30 trading days | +5.3% | 4 of 5 |
For scale, NVST’s typical 20-trading-day move in either direction is about 6.8%.
Envista market cap and key statistics
Envista’s market cap is $3.70B, with a P/E ratio of 39.2 and revenue of $2.86B over the last twelve months.
Valuation
- Market cap
- $3.70B
- P/E ratio
- 39.2
- Forward P/E
- 16.8
- EPS, TTM
- $0.58
- Gekko Fair Value
- $34.09
Trading
- Volume
- 2.39M
- Avg volume, 20 days
- 3.00M
- 52-week high
- $30.42
- 52-week low
- $18.77
- Shares outstanding
- 160.6M
Financials
- Revenue, TTM
- $2.86B
- Profit margin
- 3.3%
- Return on equity
- 3.1%
- Quarterly earnings growth, YoY
- +111.3%
Risk and income
- Beta
- 0.89
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±6.8%
Envista stock news this week
Coverage of Envista this week reads neutral: 1 positive, 3 neutral and 1 negative headlines.
- Envista Holdings Corporation (NYSE:NVST) Stock Rated “Hold” by Wall Street BrokeragesDefense World, Oct 11
- Piper Sandler cuts Envista stock price target on inventory headwinds By Investing.comInvesting.com Canada, Oct 9
- Piper Sandler cuts Envista stock price target on inventory headwindsInvesting.com, Oct 9
- Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research, Oct 9
- Envista Holdings Corporation (NVST) Stock forecastsYahoo Finance Singapore, Oct 8
- Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Stryker (SYK)The Globe and Mail, Oct 8
Envista peers
Envista’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 18.2% above |
| ABTAbbott Laboratories | Neutral | 14.7% below |
| DHRDanaher | Neutral | 4.5% above |
| ISRGIntuitive Surgical | Neutral | 18.8% above |
| MDTMedtronic | Neutral | 22.9% below |
| SYKStryker | Accumulation | 12.6% below |
A peer links to its own page where one exists.
Envista stock FAQ
What is Envista’s market cap?
Envista’s market cap is $3.70B at the Oct 12, 2026 close of $22.72, with 160.6M shares outstanding. The shares trade on a P/E ratio of 39.2.
What is the Envista stock forecast?
The consensus analyst 12-month price target for Envista is $29.69, +30.7% from the last close. Of the 15 firms that rated the stock in the last 90 days, 8 rate it a buy, 7 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Envista stock overvalued or undervalued?
On Gekko’s estimate Envista is undervalued: the Oct 12, 2026 close of $22.72 is 33.4% below Gekko Fair Value of $34.09. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Envista report earnings next?
Envista is expected to report on Nov 4, 2026, after the market closes (23 days away). Analysts expect earnings of $0.36 per share on revenue of $688.8M. Envista beat the earnings estimate in 8 of its last 8 reports, moving 7.8% on average across the report.
What is Envista’s 52-week high and low?
Envista’s 52-week high is $30.42 and its 52-week low is $18.77; it closed at $22.72 on Oct 12, 2026, +12.5% over the past year. Over the last five years the shares peaked at $52.03 on Mar 29, 2022.
Is Envista stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality), 1 as mixed (trend) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Envista the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.